How does liver cancer target treatment recover quickly?

summary

Sometimes when liver cancer occurs in the human body, it will repair itself at the beginning. In the past, the treatment of liver cancer mainly focused on surgery, not to mention that we should also understand that the curative effect of traditional chemotherapy, radiotherapy and other means has not been very ideal. In the treatment of liver cancer, liver cirrhosis, the basic disease of liver cancer, is the first problem in the treatment. It is also a very difficult problem. Many patients can not operate or liver transplantation for a long time, because of their physical condition or the toxicity of traditional chemoradiotherapy, they can not tolerate. However, the side effects of new targeted drugs are relatively less, and they can reverse some biological behaviors that induce tumor. How does liver cancer target treatment recover quickly? Let's talk about it.

How does liver cancer target treatment recover quickly?

First: at present, the mechanism of action of many targeted drugs is similar, and sorafenib is the first targeted drug for the treatment of liver cancer in clinical trials. In addition, sunitinib as a second-line drug, bevacizumab, erlotinib and other drugs have shown efficacy in phase II trials of liver cancer.

Second, there are some new small molecule targeted drugs, such as androsterol, which have been found to have good therapeutic effect on liver cancer. This drug can improve the activity of AMPK, reduce mitochondrial membrane potential and mitochondrial content, and achieve anti-inflammatory effect.

Third: at present, many projects are actively carrying out clinical investigation and development, such as: targeted drugs angiogenesis inhibitor, epidermal growth factor receptor, mammalian target protein of rapamycin, insulin-like growth factor, etc. are in different stages of development, and these targeted treatments can be provided to patients who are not willing to accept surgical resection or transplantation as the main treatment Methods of treatment.

matters needing attention

It has been confirmed that sorafenib, a multi kinase inhibitor, is effective and safe in the treatment of advanced liver cancer. The single generation of beta is effective in the treatment of liver cancer, and the effect of combined chemotherapy or other molecular targeted drugs is even more encouraging.